Connor, Clark & Lunn Investment Management (CC&L)’s Surmodics SRDX Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-7,600	Closed	-$315K	–	1163
2019 Q4	$315K	Sell	7,600 -9,750	-56%	-$411K	﹤0.01%	755
2019 Q3	$794K	Sell	17,350 -3,200	-16%	-$139K	0.01%	587
2019 Q2	$887K	Sell	20,550 -2,700	-12%	-$114K	0.01%	594
2019 Q1	$1.01M	Sell	23,250 -3,725	-14%	-$190K	0.01%	536
2018 Q4	$1.27M	Buy	26,975 +1,600	+6%	+$96K	0.01%	501
2018 Q3	$1.89M	Buy	25,375 +14,950	+143%	+$1.03M	0.01%	444
2018 Q2	$575K	Buy	+10,425	New	+$482K	﹤0.01%	745

Other funds holding SRDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s SRDX Position: Q1 2020 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Surmodics (SRDX) in Q1 2020, closing a stake of 7,600 shares — an estimated $315K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in SRDX in Q2 2018 and held it in 7 quarters. The position peaked at $1.89M in Q3 2018. 127 funds tracked by Wall St. Rank hold SRDX as of Q1 2020.

Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Surmodics position as of Q1 2020 after selling out during the quarter.
Connor, Clark & Lunn Investment Management (CC&L) sold 7,600 Surmodics shares in Q1 2020, an estimated $315K.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Surmodics in Q2 2018 and held it in 7 quarters.
Connor, Clark & Lunn Investment Management (CC&L)'s Surmodics position peaked at $1.89M in Q3 2018.
127 funds tracked by Wall St. Rank held Surmodics as of Q1 2020.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2020, filed 13 May 2020.